Literature DB >> 16342660

Spurious hypocalcemia after gadodiamide administration.

Sandra F Williams1, Shon E Meek, Thomas J Moraghan.   

Abstract

Severe hypocalcemia may require prompt intervention to avoid life-threatening consequences. We report a case in which a 78-year-old man had a critically low serum calcium level measured with use of standard colorimetric assay after gadodiamide administration during magnetic resonance angiography. Reanalysis of the same serum specimen using absorption spectroscopy revealed normal calcium values, confirming the diagnosis of spurious hypocalcemia. The increasing use of gadolinium chelates during magnetic resonance imaging and anglography will lead to a marked increase in reports of critically low serum calcium values. Increasing physicians' awareness of gadodiamide-induced spurious hypocalcemia may prevent unnecessary and potentially inappropriate therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16342660     DOI: 10.4065/80.12.1655

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Spurious hypocalcemia after gadodiamide-enhanced magnetic resonance imaging: a case report and review of the literature.

Authors:  Christopher D Moore; Robert C Newman; James G Caridi
Journal:  Rev Urol       Date:  2006

Review 2.  A review of drug-induced hypocalcemia.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  J Bone Miner Metab       Date:  2009       Impact factor: 2.626

3.  Fluid and electrolyte disturbances in critically ill patients.

Authors:  Jay Wook Lee
Journal:  Electrolyte Blood Press       Date:  2010-12-31

4.  Analytical Interference by Contrast Agents in Biochemical Assays.

Authors:  Sigrid Otnes; Niels Fogh-Andersen; Janne Rømsing; Henrik S Thomsen
Journal:  Contrast Media Mol Imaging       Date:  2017-04-10       Impact factor: 3.161

Review 5.  Interference of medical contrast media on laboratory testing.

Authors:  Giuseppe Lippi; Massimo Daves; Camilla Mattiuzzi
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.